\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\ 122\\/49\\ \\ hr\\ 88\ \(0\)\
\-\ wt\\ 50\\.2kg\\ \\ ht\\ 154\\.8cm\ \(0\)\
\-\ heart\\:\\ regular\\ rhythym\\ and\\ rate\ \(0\)\
\-\ lungs\\:\\ clear\\ to\\ auscultation\\ bilaterally\ \(0\)\
\-\ continued\\ monitoring\\ to\\ include\\ periodic\\:\ \(0\)\
\-\ \\>physical\\ exam\ \(0\)\
\-\ \\>ophthalmic\\ and\\ funduscopic\\ exam\ \(0\)\
\-\ \\>growth\\ measurements\ \(0\)\
\-\ \\>developmental\\ assessments\ \(0\)\
\-\ \\>school\\ progress\ \(0\)\
\-\ \\>renal\\ us\\/ct\ \(0\)\
\-\ \\>neuroimaging\\ \\(cranial\\ ct\\/mri\\)\ \(0\)\
\-\ surgery\\ and\\ seizure\\ watch\\ dog\\ in\\ the\\ near\\ future\\.\ \(0\)\
\-\ continue\\ medications\\ \\(as\\ above\\)\ \(0\)\
\-\ continue\\ ketogenic\\ diet\\ and\\ use\\ of\\ vns\ \(0\)\
\-\ mri\\ t2\\ axial\\ and\\ coronal\\ showing\\ multiple\\ cortical\\ lesions\\ \\-\\ high\\ signal\\ and\\ mixed\\ signal\\ intensities\\.\ \(0\)\
\-\ mri\\ t1\\ axial\\ showing\\ subependymal\\ calcifications\\/nodules\\ in\\ the\\ lateral\\ ventricles\\.\ \(0\)\
\-\ fdg\\ shows\\ abnormal\\ cerebral\\ glucose\\ metabolism\\ is\\ evident\\ where\\ there\\ are\\ multiple\\ areas\\ of\\ hypometabolism\\ in\\ the\\ regions\\ of\\ the\\ cortical\\ tubers\\.\\ \\ \ \(0\)\
\-\ amt\\ pet\\ scan\\:\\ the\\ region\\ adjacent\\ to\\ tuber\\ \\#7\\ in\\ the\\ left\\ frontal\\ cortex\\ shown\\ in\\ planes\\ 13\\,\\ 14\\,\\ and\\ 15\\ has\\ increased\\ amt\\ uptake\\.\ \(0\)\
\-\ tuberous\\ sclerosis\ \(40\)\
\-\ \\â\\€\\¢\\ migration\\ disorder\ \(0\)\
\-\ \\â\\€\\¢\\ subependymal\\ gray\\ matter\\ heterotopia\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ gliomas\ \(0\)\
\-\ \\â\\€\\¢\\ cortical\\ tubers\ \(0\)\
\-\ 14\\ y\\/o\\ girl\\ with\\ history\\ of\\ intractable\\ complex\\ partial\\ seizures\\ beginning\\ at\\ 5\\ months\\ of\\ age\\.\\ otherwise\\ in\\ good\\ general\\ health\\ requiring\\ no\\ hospitalizations\\ or\\ surgeries\\.\\ \\ she\\ uses\\ a\\ vagal\\ nerve\\ stimulator\\ \\(vns\\)\\ which\\ is\\ set\\ at\\ a\\ maximum\\ level\\ and\\ is\\ maintained\\ on\\ a\\ ketogenic\\ diet\\ which\\ have\\ helped\\ to\\ control\\ seizure\\ activity\\.\\ \\ \ \(0\)\
\-\ she\\ has\\ no\\ recent\\ history\\ of\\ cardiac\\,\\ renal\\,\\ or\\ pulmonary\\ difficulties\\.\\ \\ current\\ medications\\ include\\:\\ jolivette\\ tablet\\ \\(progesterone\\)\\,\\ keppra\\,\\ mysoline\\,\\ lamictal\\,\\ clonazepam\\,\\ diazepam\\,\\ and\\ diastat\\.\ \(0\)\
\-\ this\\ 14y\\/o\\ female\\ has\\ had\\ intractable\\ partial\\ seizures\\ that\\ began\\ at\\ 5\\ mos\\ of\\ age\\.\\ \\ the\\ patient\\ is\\ on\\ a\\ significant\\ number\\ of\\ medications\\ as\\ listed\\ above\\.\\ \\ ts\\ is\\ noted\\ to\\ involve\\ many\\ organ\\ systems\\,\\ however\\ only\\ neoplasms\\ of\\ the\\ brain\\ were\\ found\\.\\ \\ these\\ neoplasms\\ included\\:\\ cortical\\ tubers\\ and\\ subependymal\\ nodules\\ \ \(0\)\
\-\ in\\ the\\ evaluation\\ of\\ epilepsy\\,\\ meg\\(magnetoencephalography\\)\\ was\\ used\\ in\\ conjunction\\ with\\ mri\\ to\\ localize\\ the\\ source\\ of\\ the\\ seizures\\.\\ \\ this\\ is\\ important\\ because\\ surgery\\ is\\ being\\ considered\\ in\\ the\\ near\\ future\\.\ \(0\)\
\-\ a\\ video\\ eeg\\ was\\ also\\ performed\\ and\\ the\\ results\\ are\\ as\\ follows\\:\ \(0\)\
\-\ abnormal\\ due\\ to\\ presence\\ of\\:\\ 1\\)\\ several\\ tonic\\ seizures\\,\\ asymmetrical\\,\\ with\\ eye\\ and\\ head\\ deviation\\ to\\ the\\ right\\ and\\ tonic\\ posturing\\ of\\ the\\ right\\ upper\\ extremity\\ accompanied\\ with\\ generalized\\ eeg\\ changes\\;\\ 2\\)\\ right\\-sided\\ eye\\ blinking\\ accompanied\\ with\\ right\\-sided\\ predominant\\ rhythmic\\ eeg\\ activity\\ during\\ sleep\\;\\ 3\\)\\ bilateral\\ eye\\ blinking\\ accompanied\\ with\\ generalized\\ spike\\ wave\\ discharges\\ out\\ of\\ sleep\\;\\ 4\\)\\ diffuse\\ background\\ slowing\\;\\ and\\ 5\\)\\ lack\\ of\\ an\\ organized\\ sleep\\ architecture\\.\ \(0\)\
\-\ her\\ seizures\\ seemed\\ to\\ be\\ refractory\\ to\\ medical\\ treatment\\,\\ and\\ thus\\ a\\ ketogenic\\ diet\\ and\\ vagal\\ nerve\\ stimulation\\ \\(vns\\)\\ were\\ employed\\ and\\ both\\ have\\ proven\\ to\\ suppress\\ seizure\\ activity\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ketogenic\\:\\ 0\\.21492988234810725\ \(0\)\
\-\ vns\\:\\ 0\\.21492988234810725\ \(0\)\
\-\ seizures\\:\\ 0\\.182852436677083\ \(0\)\
\-\ tubers\\:\\ 0\\.1727153772629608\ \(0\)\
\-\ eeg\\:\\ 0\\.16068013968646674\ \(0\)\
\-\ and\\:\\ 0\\.15737167188607848\ \(0\)\
\-\ accompanied\\:\\ 0\\.14683167197602007\ \(0\)\
\-\ diet\\:\\ 0\\.1461861421741375\ \(0\)\
\-\ blinking\\:\\ 0\\.14328658823207152\ \(0\)\
\-\ subependymal\\:\\ 0\\.1431998258665363\ \(0\)\
\-\ sleep\\:\\ 0\\.13727876648728507\ \(0\)\
\-\ the\\:\\ 0\\.13408524500653551\ \(0\)\
\-\ amt\\:\\ 0\\.132399388366601\ \(0\)\
\-\ of\\:\\ 0\\.13150438065411152\ \(0\)\
\-\ cortical\\:\\ 0\\.12865074022319326\ \(0\)\
\-\ to\\:\\ 0\\.12319617943345175\ \(0\)\
\-\ tonic\\:\\ 0\\.1196621810482877\ \(0\)\
\-\ vagal\\:\\ 0\\.11800729298978166\ \(0\)\
\-\ intractable\\:\\ 0\\.11388636129601463\ \(0\)\
\-\ medications\\:\\ 0\\.11274173422936701\ \(0\)\
\-\ seizure\\:\\ 0\\.111835454655853\ \(0\)\
\-\ eye\\:\\ 0\\.10751520897050838\ \(0\)\
\-\ in\\:\\ 0\\.10030075207644137\ \(0\)\
\-\ activity\\:\\ 0\\.0986718809142356\ \(0\)\
\-\ mri\\:\\ 0\\.09198324972960832\ \(0\)\
\-\ future\\:\\ 0\\.089864289599684\ \(0\)\
\-\ continue\\:\\ 0\\.08789836347122466\ \(0\)\
\-\ is\\:\\ 0\\.08587950209444614\ \(0\)\
\-\ generalized\\:\\ 0\\.08554326718403274\ \(0\)\
\-\ neoplasms\\:\\ 0\\.08349568594052735\ \(0\)\
\-\ showing\\:\\ 0\\.07736151811489708\ \(0\)\
\-\ near\\:\\ 0\\.07296146518262764\ \(0\)\
\-\ rhythym\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ jolivette\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ mysoline\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ lamictal\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ clonazepam\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ diazepam\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ diastat\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ meg\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ magnetoencephalography\\:\\ 0\\.07164329411603576\ \(0\)\
\-\ nodules\\:\\ 0\\.07119098655414739\ \(0\)\
\-\ partial\\:\\ 0\\.06903393674998015\ \(0\)\
\-\ stimulator\\:\\ 0\\.06845899228645744\ \(0\)\
\-\ rhythmic\\:\\ 0\\.06845899228645744\ \(0\)\
\-\ discharges\\:\\ 0\\.06845899228645744\ \(0\)\
\-\ 14\\:\\ 0\\.06689319398633818\ \(0\)\
\-\ multiple\\:\\ 0\\.06573644298212716\ \(0\)\
\-\ above\\:\\ 0\\.06463743817658324\ \(0\)\
\-\ funduscopic\\:\\ 0\\.06444724642762609\ \(0\)\
\-\ posturing\\:\\ 0\\.06444724642762609\ \(0\)\
\-\ nerve\\:\\ 0\\.0639186960224693\ \(0\)\
\-\ tuber\\:\\ 0\\.06301539235372218\ \(0\)\
\-\ assessments\\:\\ 0\\.06180477698389427\ \(0\)\
\-\ hypometabolism\\:\\ 0\\.06180477698389427\ \(0\)\
\-\ keppra\\:\\ 0\\.06180477698389427\ \(0\)\
\-\ spike\\:\\ 0\\.06180477698389427\ \(0\)\
\-\ has\\:\\ 0\\.06138858248392991\ \(0\)\
\-\ dog\\:\\ 0\\.060756094250565267\ \(0\)\
\-\ hospitalizations\\:\\ 0\\.05983109052414385\ \(0\)\
\-\ right\\:\\ 0\\.05941083891529823\ \(0\)\
\-\ organized\\:\\ 0\\.05900364649489083\ \(0\)\
\-\ suppress\\:\\ 0\\.05900364649489083\ \(0\)\
\-\ tablet\\:\\ 0\\.05825513232225483\ \(0\)\
\-\ progesterone\\:\\ 0\\.05825513232225483\ \(0\)\
\-\ ts\\:\\ 0\\.05825513232225483\ \(0\)\
\-\ asymmetrical\\:\\ 0\\.05825513232225483\ \(0\)\
\-\ intensities\\:\\ 0\\.05636117705115902\ \(0\)\
\-\ age\\:\\ 0\\.05625046456977813\ \(0\)\
\-\ mos\\:\\ 0\\.0558193446653125\ \(0\)\
\-\ epilepsy\\:\\ 0\\.0558193446653125\ \(0\)\
\-\ renal\\:\\ 0\\.05579515995858164\ \(0\)\
\-\ slowing\\:\\ 0\\.05531249431783001\ \(0\)\
\-\ seemed\\:\\ 0\\.05531249431783001\ \(0\)\
\-\ helped\\:\\ 0\\.05483638160108283\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.0543874905914086\ \(0\)\
\-\ as\\:\\ 0\\.05399199974341679\ \(0\)\
\-\ uses\\:\\ 0\\.05396287612232529\ \(0\)\
\-\ localize\\:\\ 0\\.05396287612232529\ \(0\)\
\-\ abnormal\\:\\ 0\\.0538292338301223\ \(0\)\
\-\ architecture\\:\\ 0\\.05356004656215558\ \(0\)\
\-\ employed\\:\\ 0\\.05356004656215558\ \(0\)\
\-\ she\\:\\ 0\\.0533355103430528\ \(0\)\
\-\ include\\:\\ 0\\.05330994986669579\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.05317687522158068\ \(0\)\
\-\ conjunction\\:\\ 0\\.05317687522158068\ \(0\)\
\-\ with\\:\\ 0\\.05263318179608663\ \(0\)\
\-\ ht\\:\\ 0\\.05246243248905533\ \(0\)\
\-\ measurements\\:\\ 0\\.05212819248825168\ \(0\)\
\-\ wave\\:\\ 0\\.05212819248825168\ \(0\)\
\-\ gliomas\\:\\ 0\\.05180759880648115\ \(0\)\
\-\ axial\\:\\ 0\\.05175498376021181\ \(0\)\
\-\ heterotopia\\:\\ 0\\.05149958071527207\ \(0\)\
\-\ set\\:\\ 0\\.05149958071527207\ \(0\)\
\-\ metabolism\\:\\ 0\\.051203188761830276\ \(0\)\
\-\ listed\\:\\ 0\\.051203188761830276\ \(0\)\
\-\ difficulties\\:\\ 0\\.05091757711842376\ \(0\)\
\-\ signal\\:\\ 0\\.050790516526288645\ \(0\)\
\-\ at\\:\\ 0\\.05076340605258524\ \(0\)\
\-\ school\\:\\ 0\\.050641989030465434\ \(0\)\
\-\ periodic\\:\\ 0\\.05037574473257725\ \(0\)\
\-\ watch\\:\\ 0\\.05037574473257725\ \(0\)\
\-\ predominant\\:\\ 0\\.05037574473257725\ \(0\)\
\-\ background\\:\\ 0\\.05037574473257725\ \(0\)\
\-\ wt\\:\\ 0\\.04986889438509476\ \(0\)\
\-\ maintained\\:\\ 0\\.04962723055994124\ \(0\)\
\-\ beginning\\:\\ 0\\.04939278166834758\ \(0\)\
\-\ stimulation\\:\\ 0\\.04939278166834758\ \(0\)\
\-\ refractory\\:\\ 0\\.04916512936274933\ \(0\)\
\-\ fdg\\:\\ 0\\.04851927618959004\ \(0\)\
\-\ surgery\\:\\ 0\\.048171634300726816\ \(0\)\
\-\ surgeries\\:\\ 0\\.04754847959507101\ \(0\)\
\-\ maximum\\:\\ 0\\.04754847959507101\ \(0\)\
\-\ migration\\:\\ 0\\.04736793245678433\ \(0\)\
\-\ video\\:\\ 0\\.046849934549406655\ \(0\)\
\-\ planes\\:\\ 0\\.04620847983876925\ \(0\)\
\-\ were\\:\\ 0\\.046185141595065766\ \(0\)\
\-\ organ\\:\\ 0\\.04605598078253681\ \(0\)\
\-\ 88\\:\\ 0\\.045759588829095026\ \(0\)\
\-\ progress\\:\\ 0\\.04561548470110989\ \(0\)\
\-\ proven\\:\\ 0\\.045198389097730184\ \(0\)\
\-\ exam\\:\\ 0\\.04510364045851013\ \(0\)\
\-\ deviation\\:\\ 0\\.04506413874095941\ \(0\)\
\-\ have\\:\\ 0\\.04475907832196496\ \(0\)\
\-\ monitoring\\:\\ 0\\.044674631414056545\ \(0\)\
\-\ tuberous\\:\\ 0\\.044674631414056545\ \(0\)\
\-\ requiring\\:\\ 0\\.044674631414056545\ \(0\)\
\-\ health\\:\\ 0\\.04430353302686238\ \(0\)\
\-\ follows\\:\\ 0\\.04383453072674174\ \(0\)\
\-\ glucose\\:\\ 0\\.04328511412531059\ \(0\)\
\-\ systems\\:\\ 0\\.04328511412531059\ \(0\)\
\-\ source\\:\\ 0\\.04267284669668508\ \(0\)\
\-\ auscultation\\:\\ 0\\.04192433252404907\ \(0\)\
\-\ began\\:\\ 0\\.04166106358313056\ \(0\)\
\-\ pet\\:\\ 0\\.041490329584478215\ \(0\)\
\-\ number\\:\\ 0\\.041240992622781185\ \(0\)\
\-\ thus\\:\\ 0\\.041159608944982655\ \(0\)\
\-\ which\\:\\ 0\\.040741068134641324\ \(0\)\
\-\ involve\\:\\ 0\\.03942337059573864\ \(0\)\
\-\ ventricles\\:\\ 0\\.039358732744208\ \(0\)\
\-\ current\\:\\ 0\\.039231031481321295\ \(0\)\
\-\ developmental\\:\\ 0\\.03874003069447074\ \(0\)\
\-\ included\\:\\ 0\\.03874003069447074\ \(0\)\
\-\ regular\\:\\ 0\\.03868075905744854\ \(0\)\
\-\ hr\\:\\ 0\\.03850558180287708\ \(0\)\
\-\ evident\\:\\ 0\\.03850558180287708\ \(0\)\
\-\ regions\\:\\ 0\\.038448047079414446\ \(0\)\
\-\ gray\\:\\ 0\\.03833422690414712\ \(0\)\
\-\ lack\\:\\ 0\\.03833422690414712\ \(0\)\
\-\ control\\:\\ 0\\.03827792949727883\ \(0\)\
\-\ important\\:\\ 0\\.037948365563673495\ \(0\)\
\-\ disorder\\:\\ 0\\.037894758156703935\ \(0\)\
\-\ mixed\\:\\ 0\\.03708335796270908\ \(0\)\
\-\ growth\\:\\ 0\\.03694012989637108\ \(0\)\
\-\ continued\\:\\ 0\\.036707072597698134\ \(0\)\
\-\ cranial\\:\\ 0\\.03661575232889615\ \(0\)\
\-\ cortex\\:\\ 0\\.03648073259131382\ \(0\)\
\-\ good\\:\\ 0\\.03643623697864583\ \(0\)\
\-\ bp\\:\\ 0\\.036347994987052296\ \(0\)\
\-\ general\\:\\ 0\\.035962734683936154\ \(0\)\
\-\ coronal\\:\\ 0\\.0356756312645488\ \(0\)\
\-\ many\\:\\ 0\\.03532127997329875\ \(0\)\
\-\ where\\:\\ 0\\.035206628964428166\ \(0\)\
\-\ considered\\:\\ 0\\.03490883197392608\ \(0\)\
\-\ results\\:\\ 0\\.03490883197392608\ \(0\)\
\-\ shown\\:\\ 0\\.03472828483563939\ \(0\)\
\-\ complex\\:\\ 0\\.034516968374990076\ \(0\)\
\-\ uptake\\:\\ 0\\.034447774494541214\ \(0\)\
\-\ use\\:\\ 0\\.03427741088071348\ \(0\)\
\-\ history\\:\\ 0\\.03423159438992668\ \(0\)\
\-\ matter\\:\\ 0\\.034110664603470835\ \(0\)\
\-\ are\\:\\ 0\\.03399833779805818\ \(0\)\
\-\ rate\\:\\ 0\\.033947385237203115\ \(0\)\
\-\ 13\\:\\ 0\\.033787431548586044\ \(0\)\
\-\ used\\:\\ 0\\.033538094586889014\ \(0\)\
\-\ cardiac\\:\\ 0\\.03326673902645298\ \(0\)\
\-\ lungs\\:\\ 0\\.03306198187014183\ \(0\)\
\-\ clear\\:\\ 0\\.03247791618725633\ \(0\)\
\-\ extremity\\:\\ 0\\.03226636253019426\ \(0\)\
\-\ presence\\:\\ 0\\.032188476391384294\ \(0\)\
\-\ otherwise\\:\\ 0\\.03193429709804014\ \(0\)\
\-\ sclerosis\\:\\ 0\\.03190932583812217\ \(0\)\
\-\ girl\\:\\ 0\\.03142588371848412\ \(0\)\
\-\ because\\:\\ 0\\.031309534114467394\ \(0\)\
\-\ was\\:\\ 0\\.031225764061279027\ \(0\)\
\-\ being\\:\\ 0\\.031217679796865263\ \(0\)\
\-\ or\\:\\ 0\\.031169522830194252\ \(0\)\
\-\ heart\\:\\ 0\\.031149487287709218\ \(0\)\
\-\ cerebral\\:\\ 0\\.031037132658578572\ \(0\)\
\-\ this\\:\\ 0\\.030787460692283997\ \(0\)\
\-\ areas\\:\\ 0\\.0304153887956366\ \(0\)\
\-\ recent\\:\\ 0\\.030333367636233143\ \(0\)\
\-\ 15\\:\\ 0\\.03027240907951215\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0298776800405635\ \(0\)\
\-\ out\\:\\ 0\\.029446989397384018\ \(0\)\
\-\ several\\:\\ 0\\.029392514349179798\ \(0\)\
\-\ no\\:\\ 0\\.02913622582817867\ \(0\)\
\-\ adjacent\\:\\ 0\\.029038695297069764\ \(0\)\
\-\ found\\:\\ 0\\.02898697093033162\ \(0\)\
\-\ frontal\\:\\ 0\\.028833810947978235\ \(0\)\
\-\ medical\\:\\ 0\\.028471532878737497\ \(0\)\
\-\ during\\:\\ 0\\.028375562788826345\ \(0\)\
\-\ diffuse\\:\\ 0\\.02809449465415376\ \(0\)\
\-\ only\\:\\ 0\\.027987850566582567\ \(0\)\
\-\ her\\:\\ 0\\.027987850566582567\ \(0\)\
\-\ brain\\:\\ 0\\.027927555033342728\ \(0\)\
\-\ t1\\:\\ 0\\.027912553205232688\ \(0\)\
\-\ evaluation\\:\\ 0\\.027320920686580395\ \(0\)\
\-\ pulmonary\\:\\ 0\\.027307033053204526\ \(0\)\
\-\ changes\\:\\ 0\\.02707462492108173\ \(0\)\
\-\ level\\:\\ 0\\.027061165698203\ \(0\)\
\-\ on\\:\\ 0\\.02706011139310533\ \(0\)\
\-\ region\\:\\ 0\\.026796714631199998\ \(0\)\
\-\ head\\:\\ 0\\.026719085123063063\ \(0\)\
\-\ scan\\:\\ 0\\.02657872720211458\ \(0\)\
\-\ however\\:\\ 0\\.026515748078499404\ \(0\)\
\-\ performed\\:\\ 0\\.026503212633495525\ \(0\)\
\-\ shows\\:\\ 0\\.02629311555870807\ \(0\)\
\-\ months\\:\\ 0\\.026076620711392183\ \(0\)\
\-\ significant\\:\\ 0\\.025865934181732143\ \(0\)\
\-\ t2\\:\\ 0\\.025774079864130012\ \(0\)\
\-\ due\\:\\ 0\\.025751283172861558\ \(0\)\
\-\ lesions\\:\\ 0\\.025728552463425643\ \(0\)\
\-\ high\\:\\ 0\\.025460795121581798\ \(0\)\
\-\ these\\:\\ 0\\.02529796714738283\ \(0\)\
\-\ both\\:\\ 0\\.02498210200243666\ \(0\)\
\-\ physical\\:\\ 0\\.02429102597712091\ \(0\)\
\-\ increased\\:\\ 0\\.02422514879948019\ \(0\)\
\-\ bilateral\\:\\ 0\\.02407661567933125\ \(0\)\
\-\ upper\\:\\ 0\\.02393987186550018\ \(0\)\
\-\ noted\\:\\ 0\\.023752344425670733\ \(0\)\
\-\ had\\:\\ 0\\.02232049035176684\ \(0\)\
\-\ lateral\\:\\ 0\\.022232741342479587\ \(0\)\
\-\ female\\:\\ 0\\.02161756576546775\ \(0\)\
\-\ treatment\\:\\ 0\\.02134012304185845\ \(0\)\
\-\ also\\:\\ 0\\.021072148145764153\ \(0\)\
\-\ that\\:\\ 0\\.01944106977991336\ \(0\)\
\-\ be\\:\\ 0\\.018173148201388194\ \(0\)\
\-\ there\\:\\ 0\\.01782536822511324\ \(0\)\
\-\ an\\:\\ 0\\.017130972957419967\ \(0\)\
\-\ left\\:\\ 0\\.0152819032417008\ \(0\)\
\-\ patient\\:\\ 0\\.01457085360671095\ \(0\)\
